Autologous Dendritic Cell Vaccine in Kidney Cancer
NCT05127824
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Renal Cell
Interventions
BIOLOGICAL:
Autologous alpha-DC1/TBVA vaccine
DRUG:
Cabozantinib
Sponsor
Jodi Maranchie